European Commission logo
English English
CORDIS - EU research results
CORDIS

PexyEazy® - an innovative surgical device for treatment of haemorrhoids.

Project description

Fast and easy haemorrhoid treatment could replace conventional surgery

Haemorrhoids are clusters of vascular tissues, smooth muscles, and connective tissues that lie along the anal canal. Haemorrhoid disease, characterised by swelling, bleeding, itching, and discomfort, is one of the most common ailments. Despite its low morbidity, it has significant impact on quality of life. In severe cases, surgery is the only option. Within the last decade, mucopexy or recto anal lifting (of the hemorrhoidal prolapse) has emerged as a more conservative surgical treatment than conventional cutting or stapling. Now, PexyEazy has made that procedure easier, faster, and less expensive. Without the need for general anaesthesia, the small single-use device PexyEazy® can accomplish mucopexy within minutes. EU funding is moving the device to the clinic for trials and eventual commercialisation.

Objective

Haemorrhoids is recognized as one of the most common medical conditions in general population, effecting up to 33% of the population under the age of 50 and up to 50% of the global population over 50-years old. Haemorrhoids are swellings containing enlarged blood vessels found inside or around the bottom (the rectum and anus). They occur when the rectal mucosa falls down from its normal position, causing problems like bleeding, soiling, itching and soreness, redness and swelling. Currently available treatments like surgeries are highly invasive and are associated with postoperative pain, high frequency of relapse, stenosis (narrowing of rectum), faecal or air incontinence and long recovery time (up to 1 month). In severe cases, surgery is the only option and modern surgical treatments focus on preserving and restoring the haemorrhoids, but they are still very expensive and not affordable for almost all population affected. Developeration has developed PexyEazy®, a novel medical device aiming to revolutionize the surgical treatment of haemorrhoids. The single-use, small (<26mm in diameter) device is based on a well-documented treatment method called mucopexy by which the haemorrhoid is lifted back to its normal position by applying running sutures in the mucosa above the haemorrhoid. This reduces the swelling of the haemorrhoid and the symptoms disappear. With PexyEazy®, haemorrhoid operations can be performed without the requirement of general anaesthesia, with less postoperative complications and in only 10 minutes, resulting in significant cost savings of 70% each procedure. During the phase 1 project, a go-to-market strategy and a supply chain will be established, as well as further development plan will be drafted. Within the overall innovation project, Developeration AB will conduct clinical trials with hospitals in Sweden, where they will initially market their product, along with scaling up for commercialization.

Call for proposal

H2020-EIC-SMEInst-2018-2020

See other projects for this call

Sub call

H2020-SMEInst-2018-2020-1

Coordinator

DEVELOPERATION AB
Net EU contribution
€ 50 000,00
Address
KOTTGATAN 213
122 64 ENSKEDE
Sweden

See on map

SME

The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.

Yes
Region
Östra Sverige Stockholm Stockholms län
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Links
Total cost
€ 71 429,00